Case-control study of breast cancer in India: Role of PERIOD3 clock gene length polymorphism and chronotype
Abstract
Background: This study examined a PERIOD3 (PER3) gene variable number tandem repeat polymorphism and chronotype as potential BrCA risk factors among Indian women. Methods: This case-control study included sporadic, histologically confirmed BrCA cases (n = 255) and controls (n = 249) from India with data collection from 2010-2012. Results: Women with the 4/5 or 5/5 PER3 genotype had a nonstatistically significant 33% increased odds of BrCA. Cases were more likely to have a morning (OR = 2.43, 95% CI = 1.23-4.81) or evening (OR = 2.55, 95% CI = 1.19-5.47) chronotype. Conclusions: Findings are consistent with the possibility that extremes in chronotype may elicit circadian desynchronization, resulting in increased BrCA susceptibility. © 2014 Informa Healthcare USA, Inc.
Publication Title
Cancer Investigation
Recommended Citation
Wirth, M., Burch, J., Hébert, J., Kowtal, P., Mehrotra-Kapoor, A., Steck, S., Hurley, T., Gupta, P., Pednekar, M., Youngstedt, S., Zhang, H., & Sarin, R. (2014). Case-control study of breast cancer in India: Role of PERIOD3 clock gene length polymorphism and chronotype. Cancer Investigation, 32 (7), 321-329. https://doi.org/10.3109/07357907.2014.919305
